EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Gonadal development and function after immature testicular tissue banking as part of high‐risk gonadotoxic treatment

Aude Braye iD, Emily Delgouffe, Jutte van der Werff Ten Bosch, Inge Gies, Alina Ferster, Ellen Goossens

Pediatric Blood & Cancer · 2023

DOI: 10.1002/pbc.30370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2023. Verfasst von Aude Braye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproduction, Genetics and Regenerative Medicine (RGRG), Biology of the Testis (BITE), Vrije Universiteit Brussel (VUB), Laarbeeklaan, …. Hauptthemen laut MEDLINE: Testis, Luteinizing Hormone. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Research Program of the Research Foundation-Flanders, Kom op tegen Kanker (Stand up to Cancer-Flemish Cancer Society), Wetenschappelijk Fonds Willy Gepts of Universitair Ziekenhuis Brussel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Experimental fertility preservation programs have been started to safeguard the future fertility of prepubertal and pubertal males requiring high‐risk gonadotoxic treatment protocols. However, long‐term follow‐up studies evaluating the effects on their gonadal development and function related to the testicular biopsy procedure are rather limited.

Design

This two‐center follow‐up study (between 2002 and 2020) evaluated the gonadal development and function of a cohort of 59 prepubertal and pubertal males who have been offered immature testicular tissue banking (TTB) prior to conventional high‐risk chemo‐ and/or radiotherapy (HR‐C/R) or conditioning therapy before hematopoietic stem cell transplantation (CT‐HSCT). The aim is to investigate the long‐term impact of the testicular biopsy procedure and the high‐risk gonadotoxic treatment. Testicular growth and the reproductive hormones luteinizing hormone (LH), follicle‐stimulating hormone (FSH), testosterone (T), and inhibin B (INHB) were analyzed after treatment completion, and compared between males accepting TTB and those refusing TTB (control) as well as between HR‐C/R and CT‐HSCT treatment protocols.

Results

Of the 59 prepubertal and pubertal males included, 25 were treated by HR‐C/R and 34 required CT‐HSCT. TTB was accepted for 39 males and refused for 20 males. Most patients were prepubertal at diagnosis (85%), at TTB (79%), and at treatment completion (76%), and pubertal or postpubertal at their last follow‐up visit (66%). After 5.0 (1.0–13.0) years post treatment, most patients show normal testicular volumes (83%) and normal LH (89%), FSH (87%), T (87%), and INHB (79%) serum levels. The testicular biopsy procedure did not have an effect on testicular growth, LH, FSH, T, and INHB. Significantly more small postpubertal testicular volumes ( p = .0278) and low INHB serum levels ( p = .0130) were recorded after CT‐HSCT, especially after myeloablative conditioning.

Conclusion

The clinical follow‐up data demonstrate no effect related to the biopsy procedure, but a substantial risk for impaired gonadal development after high‐risk gonadotoxic treatment, in particular myeloablative CT‐HSCT. Longer follow‐up studies with a larger study population are needed to confirm these preliminary findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TestisLuteinizing HormoneMaleHumansFollow-Up StudiesFollicle Stimulating HormoneTestosterone

Stichwörter der Autor:innen

follow-up studygonadal functionmale fertility preservationtesticular biopsytesticular growth

Substanzen

Luteinizing HormoneFollicle Stimulating HormoneTestosterone

Autor:innen und Institutionen

  • Department of Reproduction, Genetics and Regenerative Medicine (RGRG), Biology of the Testis (BITE), Vrije Universiteit Brussel (VUB), Laarbeeklaan, Brussels, Belgium.
  • Department of Pediatrics, Division of Pediatric Oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan, Brussels, Belgium.
  • Department of Pediatrics, Division of Pediatric Endocrinology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan, Brussels, Belgium.
  • Department of Hemato-Oncology, Université Libre de Bruxelles (ULB), Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Jean Joseph Crocqlaan, Brussels, Belgium.

ORCID-Profile: Aude Braye

Förderung

  • Research Program of the Research Foundation-Flanders
  • Kom op tegen Kanker (Stand up to Cancer-Flemish Cancer Society)
  • Wetenschappelijk Fonds Willy Gepts of Universitair Ziekenhuis Brussel

Zitieren

APA

Braye, A., Delgouffe, E., van der Werff Ten Bosch, J., Gies, I., Ferster, A., & Goossens, E. (2023). Gonadal development and function after immature testicular tissue banking as part of high‐risk gonadotoxic treatment. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30370

Vancouver

Braye A, Delgouffe E, van der Werff Ten Bosch J, Gies I, Ferster A, Goossens E. Gonadal development and function after immature testicular tissue banking as part of high‐risk gonadotoxic treatment. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30370

BibTeX
@article{Braye2023,
  author = {Braye, Aude and Delgouffe, Emily and van der Werff Ten Bosch, Jutte and Gies, Inge and Ferster, Alina and Goossens, Ellen},
  title = {Gonadal development and function after immature testicular tissue banking as part of high‐risk gonadotoxic treatment},
  journal = {Pediatric Blood & Cancer},
  year = {2023},
  doi = {10.1002/pbc.30370}
}
Kostenlos starten →